Clinical Trial

A Study of Topical Duvelisib in Participants With Early-stage Mycosis Fungoides

Not Yet Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study will evaluate the safety and preliminary efficacy of duvelisib topical gel in participants with early-stage mycosis fungoides.
Trial Details
NCT Number NCT07714187
Lead Sponsor SecuraBio
Conditions Mycosis Fungoides, Cutaneous T-cell Lymphoma
Enrollment 30 participants
Start Date 2027-01
Primary Completion 2028-10 (estimated)
Study Completion 2029-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-20